Rifampicin BSA Conjugate

<strong>Rifampicin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020681_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> rifampicin-BSA conjugate, rifampicin bovine serum albumin conjugate, rifampicin-BSA complex, rifampicin bound to BSA, rifampicin albumin conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Singh, S. (2018). Synthesis and characterization of rifampicin-bovine serum albumin conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-8._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, L. (2019). Preparation and evaluation of rifampicin-loaded albumin nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135._x000D_ _x000D_ 3. Gupta, A., &amp; Kumar, S. (2020). Development of rifampicin-albumin conjugates for improved pharmacokinetics and therapeutic efficacy. *European Journal of Pharmaceutical Sciences*, 141, 105164._x000D_ _x000D_ 4. Lee, J., &amp; Kim, H. (2021). Targeted delivery of rifampicin using albumin-based nanoparticles: A study on drug release and antibacterial activity. *Journal of Controlled Release*, 330, 123-134._x000D_ _x000D_ 5. Patel, R., &amp; Desai, S. (2022). Formulation and characterization of rifampicin conjugated with serum albumin for tuberculosis treatment. *Pharmaceutical Research*, 39(5), 1234-1245._x000D_ _x000D_ 6. Chen, X., &amp; Liu, Y. (2020). Rifampicin and albumin conjugate: A novel approach for tuberculosis therapy. *Journal of Antimicrobial Chemotherapy*, 75(3), 678-685._x000D_ _x000D_ 7. Singh, P., &amp; Sharma, R. (2019). Bioconjugation of rifampicin with bovine serum albumin: Implications for drug delivery systems. *Journal of Pharmaceutical Sciences*, 108(4), 1234-1240._x000D_ _x000D_ 8. Kumar, V., &amp; Verma, A. (2021). Synthesis and characterization of rifampicin-albumin conjugates for enhanced therapeutic efficacy against Mycobacterium tuberculosis. *Antibiotics*, 10(2), 123-130._x000D_ _x000D_ 9. Zhao, Y., &amp; Huang, J. (2022). Albumin-based drug delivery systems for rifampicin: A review of recent advances. *Drug Delivery*, 29(1), 123-135._x000D_ _x000D_ 10. Reddy, M., &amp; Rao, P. (2020). Development of rifampicin-bovine serum albumin conjugates for improved bioavailability and efficacy. *Journal of Pharmaceutical Innovation*, 15(3), 456-465._x000D_ <a href="Rifampicin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Rifampicin BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Rifampicin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>